Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $1.90 per share which met the analyst consensus estimate. This is a 131.71 percent increase over earnings of $0.82 per share from the same period last year. The company reported quarterly sales of $658.412 million which beat the analyst consensus estimate of $627.582 million by 4.91 percent. This is a 65.94 percent increase over sales of $396.781 million the same period last year.